Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress

Melody Hermel; Megan Pelter; Timothy Jordan; Azka Latif; Mohamed M. Gad; Leandro Slipczuk; Dinesh Kalra; Salim S. Virani

doi:10.1007/s11883-022-01072-0

Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress

Melody Hermel
, Megan Pelter
, Timothy Jordan
, Azka Latif
, Mohamed M. Gad
, Leandro Slipczuk
, Dinesh Kalra
, Salim S. Virani

Research output: Contribution to journal › Review article › peer-review

4 Citations (Scopus)

Abstract

Purpose of Review: Focused review of select studies presented at the 2022 European Society of Cardiology Congress. Recent Findings: Included studies assessed the effects of aspirin and omega-3 fatty acid supplements on heart failure (ASCEND study); the impact of icosapent ethyl on ST-elevation MI incidence (REDUCE-IT); air temperature’s effect on cardiovascular mortality (EXHAUSTION project); LVEF outcomes after troponin-guided neurohormonal blockade for the prevention of anthracycline toxicity; efficacy of routine stress testing after high-risk PCI (POST-PCI trial); influenza vaccine among patients with acute coronary syndromes (VIP-ACS trial); empagliflozin in patients with acute myocardial infarction (EMMY); effects of comprehensive imaging-based cardiovascular screening on death and cardiovascular events (DANCANVAS); safety of long-term evolocumab in patients with established atherosclerotic cardiovascular disease (FOURIER-OLE); and use of a cardiovascular polypill as a global strategy to improve secondary prevention (SECURE). Summary: Research presented at the 2022 ESC Congress highlighted many novel applications of preventative and treatment strategies in cardiology, including the effects of environmental risk factors on the incidence of cardiovascular disease.

Original language	English (US)
Pages (from-to)	981-993
Number of pages	13
Journal	Current Atherosclerosis Reports
Volume	24
Issue number	12
DOIs	https://doi.org/10.1007/s11883-022-01072-0
Publication status	Published - Dec 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Acute coronary syndrome
Cardiovascular disease
Empagliflozin
Evolocumab
Heart failure
PCSK-9 inhibitor
Prevention

Access to Document

10.1007/s11883-022-01072-0

Cite this

@article{83c025ff516046b0acbed811377a60f2,

title = "Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress",

abstract = "Purpose of Review: Focused review of select studies presented at the 2022 European Society of Cardiology Congress. Recent Findings: Included studies assessed the effects of aspirin and omega-3 fatty acid supplements on heart failure (ASCEND study); the impact of icosapent ethyl on ST-elevation MI incidence (REDUCE-IT); air temperature{\textquoteright}s effect on cardiovascular mortality (EXHAUSTION project); LVEF outcomes after troponin-guided neurohormonal blockade for the prevention of anthracycline toxicity; efficacy of routine stress testing after high-risk PCI (POST-PCI trial); influenza vaccine among patients with acute coronary syndromes (VIP-ACS trial); empagliflozin in patients with acute myocardial infarction (EMMY); effects of comprehensive imaging-based cardiovascular screening on death and cardiovascular events (DANCANVAS); safety of long-term evolocumab in patients with established atherosclerotic cardiovascular disease (FOURIER-OLE); and use of a cardiovascular polypill as a global strategy to improve secondary prevention (SECURE). Summary: Research presented at the 2022 ESC Congress highlighted many novel applications of preventative and treatment strategies in cardiology, including the effects of environmental risk factors on the incidence of cardiovascular disease.",

keywords = "Acute coronary syndrome, Cardiovascular disease, Empagliflozin, Evolocumab, Heart failure, PCSK-9 inhibitor, Prevention",

author = "Melody Hermel and Megan Pelter and Timothy Jordan and Azka Latif and Gad, \{Mohamed M.\} and Leandro Slipczuk and Dinesh Kalra and Virani, \{Salim S.\}",

note = "Publisher Copyright: {\textcopyright} 2022, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.",

year = "2022",

month = dec,

doi = "10.1007/s11883-022-01072-0",

language = "English (US)",

volume = "24",

pages = "981--993",

journal = "Current Atherosclerosis Reports",

issn = "1523-3804",

publisher = "Springer",

number = "12",

}

TY - JOUR

T1 - Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress

AU - Hermel, Melody

AU - Pelter, Megan

AU - Jordan, Timothy

AU - Latif, Azka

AU - Gad, Mohamed M.

AU - Slipczuk, Leandro

AU - Kalra, Dinesh

AU - Virani, Salim S.

PY - 2022/12

Y1 - 2022/12

N2 - Purpose of Review: Focused review of select studies presented at the 2022 European Society of Cardiology Congress. Recent Findings: Included studies assessed the effects of aspirin and omega-3 fatty acid supplements on heart failure (ASCEND study); the impact of icosapent ethyl on ST-elevation MI incidence (REDUCE-IT); air temperature’s effect on cardiovascular mortality (EXHAUSTION project); LVEF outcomes after troponin-guided neurohormonal blockade for the prevention of anthracycline toxicity; efficacy of routine stress testing after high-risk PCI (POST-PCI trial); influenza vaccine among patients with acute coronary syndromes (VIP-ACS trial); empagliflozin in patients with acute myocardial infarction (EMMY); effects of comprehensive imaging-based cardiovascular screening on death and cardiovascular events (DANCANVAS); safety of long-term evolocumab in patients with established atherosclerotic cardiovascular disease (FOURIER-OLE); and use of a cardiovascular polypill as a global strategy to improve secondary prevention (SECURE). Summary: Research presented at the 2022 ESC Congress highlighted many novel applications of preventative and treatment strategies in cardiology, including the effects of environmental risk factors on the incidence of cardiovascular disease.

AB - Purpose of Review: Focused review of select studies presented at the 2022 European Society of Cardiology Congress. Recent Findings: Included studies assessed the effects of aspirin and omega-3 fatty acid supplements on heart failure (ASCEND study); the impact of icosapent ethyl on ST-elevation MI incidence (REDUCE-IT); air temperature’s effect on cardiovascular mortality (EXHAUSTION project); LVEF outcomes after troponin-guided neurohormonal blockade for the prevention of anthracycline toxicity; efficacy of routine stress testing after high-risk PCI (POST-PCI trial); influenza vaccine among patients with acute coronary syndromes (VIP-ACS trial); empagliflozin in patients with acute myocardial infarction (EMMY); effects of comprehensive imaging-based cardiovascular screening on death and cardiovascular events (DANCANVAS); safety of long-term evolocumab in patients with established atherosclerotic cardiovascular disease (FOURIER-OLE); and use of a cardiovascular polypill as a global strategy to improve secondary prevention (SECURE). Summary: Research presented at the 2022 ESC Congress highlighted many novel applications of preventative and treatment strategies in cardiology, including the effects of environmental risk factors on the incidence of cardiovascular disease.

KW - Acute coronary syndrome

KW - Cardiovascular disease

KW - Empagliflozin

KW - Evolocumab

KW - Heart failure

KW - PCSK-9 inhibitor

KW - Prevention

UR - https://www.scopus.com/pages/publications/85141601379

U2 - 10.1007/s11883-022-01072-0

DO - 10.1007/s11883-022-01072-0

M3 - Review article

C2 - 36346504

AN - SCOPUS:85141601379

SN - 1523-3804

VL - 24

SP - 981

EP - 993

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

IS - 12

ER -

Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this